Mesoblast Limited Form 6-K Summary
Business Context and Reporting Period
Mesoblast Limited, an Australian company, filed this Form 6-K on December 4, 2015, covering the month of November 2015. The filing serves to disclose a regulatory submission made to the Australian Securities Exchange (ASX) on November 30, 2015.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of a corporate governance event rather than a financial statement.
Material Changes
The material change disclosed is the submission of a Change in Director's Interest Notice to the ASX. This notice pertains to Dr. Ben-Zion Weiner, as detailed in Exhibit 99.1 attached to the report.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the notification of the director's interest change.
Key Facts for Investor Verification
- Verify the specific details of the Change in Director's Interest Notice for Dr. Ben-Zion Weiner in Exhibit 99.1.
- Confirm the date of the ASX submission (November 30, 2015) against the filing date (December 4, 2015).
- Note that this filing contains no financial performance data for the period.